Europe and Israel Mobile Applications for Melanoma Detection Market, By Type (Algorithm Analysis Applications, Mole Tracking And Reminder Applications, Educational Applications, Interactive Teaching Applications), By End User (Diagnostic Centers, Patients, Hospitals, Skincare Clinics), By Regions (Europe (UK, Germany, Italy, France, Spain, Russia, Rest of Europe), Israel) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

Published In : Sep 2021

Code : CMI4642

Pages :172

Formats :

Excel and PDF

Industry : Healthcare IT

Market News

Recent Developments:

In August 2021, Digital Diagnostics (formerly known as IDx) has acquired dermatology focused startup 3Derm. In 2018 Digital Diagnostics landed a De Novo to market its AI-based software system for the autonomous detection for diabetic retinopathy in adults who have diabetes named IDx-DR.

In September 2020, Skin Analytics, a U.K.-based startup that has developed a skin cancer screening service that uses artificial intelligence, has raised £4 million in Series A funding. The round was led by Hoxton Ventures, with participation from Nesta and Mustard Seed Ventures.

In October 2019, a study published in the Journal of the European Academy of Dermatology and Venereology, investigators tested the app’s claimed that SkinVision app can play a crucial role in early skin cancer detection. They concluded that it is around 95.1% sensitive in its ability to identify the most common forms of skin cancer.

Europe and Israel Mobile Applications for Melanoma Detection Market: Key Developments

October 2019: SkinVision, achieved three ISO certifications. The British Standards Institution (BSI), awarded SkinVision ISO 13485:2016 for its quality management system. BSI awarded the company ISO 27001:2013 for information security management, as well as the Dutch national standard NEN 7510:2017, which includes additional requirements to ISO 27001:2013, specifically for healthcare providers in the Netherlands.